Yuanyuan Zhang

Yuanyuan Zhang

Auto-generated profile, based on publicly available information

Yuanyuan Zhang

Department of Respiratory Medicine Ministry of Education Key Laboratory of Child Development and Disorders Chongqing Key Laboratory of Pediatrics Children's Hospital of Chongqing Medical University National Clinical Research Center for Child Health and Disorders Chongqing China

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 May 2025 in Pediatric Discovery
Verified
Journal Article
Open access
YZYuanyuan Zhang
Yuanyuan Zhang
FYFuping Yang
Fuping Yang
CYChunyu Yan
Chunyu Yan
YDYu Deng
Yu Deng
ELEnmei Liu
Enmei Liu
Asthma, chronic pulmonary obstructive disease (COPD), cystic fibrosis, and acute respiratory infections are severe respiratory conditions that significantly contribute to global morbidity and mortality. Airway mucus hypersecretion is an important common pathophysiological and clinical manifestation of these diseases and is closely associated with adverse clinical outcomes. At present, the management of airway mucus hypersecretion lacks a viable clinical intervention. However, the revelation that the EGFR signaling pathway acts as a convergent intracellular pathway for many inflammatory mediators indicates that it exhibits the greatest potential for inhibiting excessive mucus production. This review provides a comprehensive overview of the role of EGFR in airway mucus hypersecretion and the therapeutic progress of targeting it, intending to improve clinicians' understanding of the mechanism and offer insights and recommendations for developing novel pharmaceutical interventions to regulate mucus secretion.